OXURION announces its presence at the Paris SmallCap event on March 28, 2024. Leuven, BELGIUM - March 25, 2024 - 7:00 p.m, Oxurion NV (Euronext Brussels : OXUR), a Leuven-based biopharmaceutical company, is pleased to announce its participation in the SmallCap event, scheduled for March 28 in Paris. The event, organized in key cities such as Paris, London, Frankfurt and Amsterdam, serves as a platform for bringing together European issuers and a wider network of institutional investors and...